ECONOMIC OUTCOMES OF ANTIDEPRESSANT USE IN A MANAGED CARE ORGANIZATION
Author(s)
White, TJ1, Nichol MB2; 1Prescription Solutions – A subsidiary of PacifiCare Health Systems, Costa Mesa, CA, USA; 2University of Southern California School of Pharmacy, Los Angeles, CA, USA
Managed care organizations are striving to seek ways to provide cost-effective care for patients with major depression. OBJECTIVE: The primary objective is to determine the relationship between antidepressant utilization patterns (treatment completion, switching, and augmentation) and overall health care costs from a managed care perspective. The secondary objective is to investigate differences between specific antidepressants regarding these outcomes. The inquiry is guided by the question: Which factors contribute to overall health care service expenditures for the treatment of depression? METHODS: Retrospective computerized claims records from a large managed care organization were analyzed (N=2,379). Treatment completion is defined as receiving at least 180 days of therapy at a minimum therapeutic dose defined by the AHCPR guidelines. Patients were included if they had a new ICD-9 diagnosis code for depression and were newly initiated on antidepressant therapy. Patients were excluded if they were less than 18 years old, had a diagnosis indicating schizophrenia or bipolar depression, did not have at least 9 months of follow up data available, or were ineligible for coverage by the plan. RESULTS: Total drug costs were higher in patients who completed therapy ($704 vs $311; P<0.001); however overall health care costs were similar ($2672 vs $2623, P=0.84). After controlling for confounding factors, there was a significant relationship between overall cost and the specific antidepressant selected. Total costs were similar for patients who switched or augmented with a second antidepressant. CONCLUSION: Patients with a diagnosis of depression who complete therapy have similar overall health care costs compared to those who do not. The initial antidepressant selected significantly contributes to overall costs.
Conference/Value in Health Info
1999-05, ISPOR 1999, Arlington, VA, USA
Value in Health, Vol. 2, No. 3 (May/June 1999)
Code
PNP4
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Mental Health